Colgate-Palmolive (NYSE:CL) Holdings Lifted by Profund Advisors LLC

Profund Advisors LLC lifted its holdings in shares of Colgate-Palmolive (NYSE:CL) by 5.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 22,577 shares of the company’s stock after acquiring an additional 1,191 shares during the quarter. Profund Advisors LLC’s holdings in Colgate-Palmolive were worth $1,703,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Jacobi Capital Management LLC raised its holdings in shares of Colgate-Palmolive by 125.5% during the 3rd quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock worth $104,000 after buying an additional 803 shares in the last quarter. Krilogy Financial LLC grew its position in Colgate-Palmolive by 23.0% during the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after acquiring an additional 289 shares during the last quarter. Captrust Financial Advisors bought a new stake in Colgate-Palmolive during the 2nd quarter worth $122,000. Bruderman Asset Management LLC bought a new stake in Colgate-Palmolive during the 2nd quarter worth $126,000. Finally, Calton & Associates Inc. bought a new stake in shares of Colgate-Palmolive in the 4th quarter valued at about $126,000. Institutional investors own 73.64% of the company’s stock.

Several brokerages recently commented on CL. KeyCorp restated a “hold” rating on shares of Colgate-Palmolive in a research report on Saturday, November 25th. Societe Generale downgraded Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 price target on the stock. in a research note on Wednesday, November 29th. They noted that the move was a valuation call. Deutsche Bank began coverage on Colgate-Palmolive in a research note on Wednesday, December 13th. They issued a “hold” rating and a $75.00 price objective for the company. Macquarie raised Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price objective for the company in a research note on Tuesday, December 19th. Finally, Zacks Investment Research lowered Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Tuesday, December 19th. Three equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $77.71.

In related news, VP Henning I. Jakobsen sold 36,215 shares of the stock in a transaction dated Monday, February 5th. The shares were sold at an average price of $71.22, for a total value of $2,579,232.30. Following the sale, the vice president now directly owns 70,783 shares of the company’s stock, valued at approximately $5,041,165.26. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Jennifer Daniels sold 902 shares of the firm’s stock in a transaction that occurred on Tuesday, January 9th. The stock was sold at an average price of $75.82, for a total transaction of $68,389.64. Following the transaction, the insider now directly owns 37,788 shares in the company, valued at $2,865,086.16. The disclosure for this sale can be found here. Insiders have sold a total of 455,707 shares of company stock valued at $32,443,427 in the last three months. Insiders own 1.02% of the company’s stock.

Colgate-Palmolive stock traded up $0.36 during mid-day trading on Monday, hitting $69.98. 2,855,954 shares of the stock traded hands, compared to its average volume of 4,062,251. Colgate-Palmolive has a 1 year low of $68.19 and a 1 year high of $77.91. The stock has a market capitalization of $60,940.25, a price-to-earnings ratio of 30.95, a price-to-earnings-growth ratio of 2.58 and a beta of 0.79. The company has a quick ratio of 1.00, a current ratio of 1.36 and a debt-to-equity ratio of 27.02.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 26th. The company reported $0.75 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.75. Colgate-Palmolive had a net margin of 13.10% and a return on equity of 1,716.69%. The business had revenue of $3.89 billion during the quarter, compared to analyst estimates of $3.92 billion. During the same period in the previous year, the business earned $0.75 EPS. The company’s quarterly revenue was up 4.6% compared to the same quarter last year. analysts forecast that Colgate-Palmolive will post 3.18 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, May 15th. Investors of record on Friday, April 20th will be issued a $0.42 dividend. The ex-dividend date is Thursday, April 19th. This represents a $1.68 annualized dividend and a yield of 2.40%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.40. Colgate-Palmolive’s dividend payout ratio is currently 70.18%.

TRADEMARK VIOLATION WARNING: This article was posted by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be viewed at

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with's FREE daily email newsletter.

Leave a Reply